stockrow
Friday 6 November 2026
Export ORKA’s income statement to Excel — free account
Oruka Therapeutics, Inc.
ORKA Healthcare Biotechnology
- EPS
- −19.6%
- Free cash flow
- −43.0%
Quarter to June 2026, against a year earlier
102.68
6.66
+6.94%
Follow ORKA
Alert me
Oruka Therapeutics, Inc. (ORKA) Operating cash flow
Oruka Therapeutics, Inc.'s operating cash flow for fiscal 2025 was −$88.2M, compared with −$57.8M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$100.9M. Over the past ten years it has ranged from −$88.2M (fiscal 2025) to −$4.8M (fiscal 2019) — the current reading is the lowest in ten years. Oruka Therapeutics, Inc. ranks 457th of 603 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | −$88.2M | — |
| FY2024 | −$57.8M | — |
| FY2023 | −$5.0M | — |
| FY2022 | −$10.9M | — |
| FY2021 | −$18.8M | — |
| FY2020 | −$7.7M | — |
| FY2019 | −$4.8M | — |
| FY2018 | −$8.2M | — |
| FY2017 | −$17.5M | — |
| FY2016 | −$15.0M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | −$33.1M | — |
| Mar 2026 | −$23.6M | — |
| Dec 2025 | −$22.6M | — |
| Sep 2025 | −$21.6M | — |
| 42 more quarters | Free account |
Against its own ten years
Low −$88.2M
High −$4.8M
Ten-year median
−$10.9M
Current reading's percentile
9
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| LGND Ligand Pharmaceuticals Incorporated compare | $91.0M |
| BLTE Belite Bio, Inc. Sponsored ADR compare | −$66.2M |
| AXSM Axsome Therapeutics, Inc. compare | −$81.8M |
| ORKA Oruka Therapeutics, Inc. | −$100.9M |
| KOD Kodiak Sciences Inc. compare | −$158.5M |
| CGON CG Oncology, Inc. compare | −$178.5M |
| MIRM Mirum Pharmaceuticals, Inc. compare | −$271.3M |
| IMVT Immunovant, Inc. compare | −$414.3M |
| IONS Ionis Pharmaceuticals, Inc. compare | −$496.4M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item